About the Authors
- Christoph Scheich
-
Contributed equally to this work with: Christoph Scheich, Zoltán Szabadka
Current address: Evotec AG, Hamburg, Germany
Affiliation Combinature Biopharm AG, Berlin, Germany
- Zoltán Szabadka
-
Contributed equally to this work with: Christoph Scheich, Zoltán Szabadka
Affiliations Department of Computer Science, Eötvös University, Budapest, Hungary, Uratim Ltd., Budapest, Hungary
- Beáta Vértessy
-
Affiliations Institute of Enzymology, Hungarian Academy of Science, Budapest, Hungary, Department of Applied Biotechnology, University of Technology and Economics, Budapest, Hungary
- Vera Pütter
-
Current address: Bayer Schering Pharma AG, Berlin, Germany
Affiliation Combinature Biopharm AG, Berlin, Germany
- Vince Grolmusz
-
* E-mail: grolmusz@cs.elte.hu (VG); markus.schade@astrazeneca.com (MS)
Affiliations Department of Computer Science, Eötvös University, Budapest, Hungary, Uratim Ltd., Budapest, Hungary
- Markus Schade
-
* E-mail: grolmusz@cs.elte.hu (VG); markus.schade@astrazeneca.com (MS)
Current address: AstraZeneca Ltd, DS Biophysics, Macclesfield, United Kingdom
Affiliation Combinature Biopharm AG, Berlin, Germany
Competing Interests
One or more of the authors have an affiliation to commercial funders, namely Uratim Ltd, Evotec AG, Bayer Schering Pharma AG and AstraZeneca Ltd, of biopharmaceutical research. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: CS ZS BV VP VG MS. Performed the experiments: CS ZS VP VG MS. Analyzed the data: CS ZS BV VP VG MS. Contributed reagents/materials/analysis tools: CS ZS VP VG MS. Wrote the paper: CS ZS BV VG MS.